Cortex Announces Update on CX717 Clinical Hold.

Business WireJune 08, 2006

Linked as:

Extract


Cortex Announces Update on CX717 Clinical Hold.

IRVINE, Calif. -- Cortex Pharmaceuticals, Inc. (AMEX: COR) announced that it has provided to the U.S. Food and Drug Administration the preclinical research p...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company